AcelRx Pharmaceuticals
ACRX
#9653
Rank
โ‚ฌ13.59 M
Marketcap
0,80ย โ‚ฌ
Share price
7.50%
Change (1 day)
40.82%
Change (1 year)

EPS for AcelRx Pharmaceuticals (ACRX)

EPS in 2023 (TTM): -2,94ย โ‚ฌ

According to AcelRx Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -2,88ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 5,08ย โ‚ฌ an increase over its 2021 EPS that were of -5,41ย โ‚ฌ.

EPS history for AcelRx Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,94ย โ‚ฌ-157.95%
20225,08ย โ‚ฌ-193.97%
2021-5,41ย โ‚ฌ-39.58%
2020-8,95ย โ‚ฌ-28.36%
2019-12,49ย โ‚ฌ-18.29%
2018-15,29ย โ‚ฌ-25.45%
2017-20,51ย โ‚ฌ17.02%
2016-17,53ย โ‚ฌ67.86%
2015-10,44ย โ‚ฌ-26.32%
2014-14,17ย โ‚ฌ15.15%
2013-12,31ย โ‚ฌ-56.29%
2012-28,15ย โ‚ฌ27.97%
2011-22,00ย โ‚ฌ-92.99%
2010-313,63ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,92ย โ‚ฌ-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA